Screen and Stage Legend Phylicia Rashad Launches a Campaign Close to Her Heart
One of America's best-loved TV moms, The Cosby Show's Phylicia Rashad is taking on a new leading role in
raising awareness of Peripheral Artery Disease (P.A.D.), a condition that affects about 8 million Americans, and puts them at more than double the risk of heart attack or stroke and more than four times the risk of dying from heart disease including heart attack and stroke. However, according to the P.A.D. Coalition, most people are unaware of P.A.D. and the risks associated with it.
Read more ...
European Commission Launches Consultation on Pharmaceuticals
The European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals. In an explanatory note, the Commission highlights three major challenges impacting the pharmaceutical sector in Europe: the globalisation of the sector; the smooth functioning of the internal market; and advances in science and technology.
Read more ...
EU committee recommends omega-3 supplements during pregnancy
Pregnant women should take a daily supplement of omega-3 acids, an EU supported consensus committee has recommended. The supplement would increase the likelihood of a healthy birth and boost child development. The committee, composed of more than 50 nutritional experts from the EU-funded projects Perinatal Lipid Nutrition Group (PeriLip) and Early Nutrition Programming (EARNEST), said it had found that women who included DHA in their diet had healthier pregnancies, that their children had healthier birth weights and that they were less likely to give birth prematurely.
Read more ...
International Study Finds New Drugs Combination to Cut Deaths from Diabetes
The largest-ever study of treatments for diabetes has shown that a combination of two blood pressure-lowering drugs reduces the risk of death, heart attack and kidney disease in diabetes sufferers. The "Action in diabetes and vascular disease" (ADVANCE) project involves 20 countries from around the world, 12 of them from the EU. The results were presented at the European Society of Cardiology Congress in Vienna, Austria, on 3 September.
Read more ...
The Future of Pharmaceuticals for Human Use in Europe
The European pharmaceutical industry makes an irreplaceable contribution to Europe's wellbeing through the availability of medicines, economic growth and employment. The pharmaceutical sector has been and remains a key strategic sector for Europe.
Read more ...
Study Trends Online Professional Activities and Reveals Specialty-specific Marketing Opportunities
Manhattan Research, a healthcare market research services firm, announced the leading pharmaceutical product website destinations for physicians from its new physician research study, "ePharma Physician® v7.0: The Future of Professional eMarketing.". Manhattan Research recently hosted a webcast discussing highlights of the ePharma Physician® v7.0 research.
Read more ...
Putnam Associates Study Finds Insurers Want More Prescription Drug Use
Putnam Associates released today the results of an intensive study of U.S. health insurance plans' perceptions of branded prescription drug use in the U.S. The study revealed that plans believe greater pharmacoeconomic value can be unlocked by increasing patient use within certain drug categories.
Read more ...
The European Commission has launched a consultation on the future of pharmaceuticals for human use in Europe, as a part of its programme to improve the regulatory, non-regulatory and research, technology and development framework for pharmaceuticals. In an explanatory note, the Commission highlights three major challenges impacting the pharmaceutical sector in Europe: the globalisation of the sector; the smooth functioning of the internal market; and advances in science and technology. 
Manhattan Research, a healthcare market research services firm, announced the leading pharmaceutical product website destinations for physicians from its new physician research study, "ePharma Physician® v7.0: The Future of Professional eMarketing.". Manhattan Research recently hosted a webcast discussing highlights of the ePharma Physician® v7.0 research.